Shingles Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Antiviral medications, Narcotic medications, Anti-inflammatory medications, Antihistamines, Anticonvulsants, Creams and Others), By Route of Administration (Tablets and Injections), By End-use (Clinics, Hospitals, Diagnostic Centers and Home Care Settings) and By Geography (EU, NA, APAC, LATAM, and MEA) – Analysis, Size, Share, Trends, & Forecast from 2021-2027
REPORT HIGHLIGHT
The global shingles treatment market was valued at USD 4.36 billion by 2020, growing with 17.1% CAGR during the forecast period, 2021-2027.
Shingle is a viral disease that creates a severe rash. This is caused by a microorganism called varicella-zoster, a similar one that causes chickenpox disease. The virus can be excruciating. Nevertheless, the condition can be cured by antibiotics. Immediate treatment can also prevent it from becoming more critical and causing more pain to the sufferers. The disease is more prevalent in people beyond the age of 45 years. Still, the infection can attack anybody with a low immune system.
It is not a life-threatening disease, but it can be intense. Medications, including antibiotics, vaccines can further decrease the risk of shingles. The most common difficulty is postherpetic neuralgia, which creates pain for an extended time after blisters or sores have cleared.
Market Dynamics
The increasing collaborations between the principal players for acquiring the Intellectual Property Rights (IPRs), having in mind the goal to produce the molecule through authorized innovation, is expected to foster the growth of the shingles treatment market. The pharmaceutical market is currently boosting 25% a year. Prevailing medications for treatment are promptly generating an accelerated market to keep sufferers healthier and reduce costs by omitting additional hospitalizations. Vaccinations include Valacyclovir (Valtrex), Acyclovir (Zovirax), and Famciclovir (Famvir). The rising predominance of drugs/vaccines coupled with evolving interest for quick-acting and more effective prescriptions is estimated to accelerate shingles treatment market growth. The growing geriatric population is filling the predominance of conditions, for instance, cancer and skin infections. The pervasiveness of shingles is growing over the globe, fuelled essentially by an expanding growing populace. It is estimated that around 210,000 people in the United Kingdom suffer from this disease every year; the majority of them are more than 50 years.
Treatment Type Takeaway
The global business is classified into the whole detection of antiviral medications, narcotic medications, anti-inflammatory medications, antihistamines, anticonvulsants, creams, and others based on treatment type. The instruments segment accounted for the lion's share in the Antiviral medications market in terms of both volume and value in 2019 and is projected to grow at a notable CAGR during the analysis period. Antiviral drugs, including acyclovir, valacyclovir, and famciclovir, are used to manage this disease and decrease the illness's time and severity. These drugs are most effective if the patient starts using them as soon as possible after dermatitis appears. Factors such as an increase in the geriatric population, rise in population growth, nanotechnology's launch to advance antiviral medication, growing prevalence of shingles, and technological improvements in antiviral medications stimulate market growth. Nevertheless, the high cost of drugs and stringent governing approvals limit the market growth.
Route of Administration Takeaway
The worldwide industry is categorized into tablets and injections in terms of route of administration. The injections segment is likely to dominate the shingles treatment market growth shortly. The foremost factors accountable for the growth of the injections market are the growing use of vaccines, the surge in the prevalence of infections such as shingles, snowballing occurrence of needlestick injuries, and the benefits offered by injections (ease of use, convenience, and reduced pain). These factors have augmented the need for injections.
End-Use Takeaway
The global business is classified into Clinics, Hospitals, Diagnostic centers, and Home Care Settings based on end-use. The hospital segment accounted for a remarkable share in the market in terms of both volume and value in 2019 and is expected to grow at a striking growth rate by 2027. The increasing cases of shingles and HIV cases are leading to high hospital visits which is a positive driving factor for the shingles treatment market growth.
Regional Takeaway
Regionally, the overall industry is divided into Europe, North America, Middle East & Africa, Asia Pacific, and Latin America. The rising prevalence of viral infection and increasing interest in over-the-counter pain medicines, antiviral prescriptions, and topical anti-infection agents for shingles treatment are likely to contribute to market growth over this region. Moreover, high R&D investment and frequent product approvals are vital drivers responsible for the market's substantial share in this region.
On the flip side, Asia Pacific accounts for the fastest-growing segment of the shingles treatment market. Improving the superiority of hospital services and the growing number of private players in nations such as India, China & Thailand are anticipated to spur the regional shingles treatment market's growth.
COVID-19 Impact
The emergence of the COVID-19 pandemic brought the world together to a standstill. The vast health crisis due to the virus also brought an unusual impact on numerous businesses across every vertical. However, the shingles treatment market has seen constant growth owing to the continuous requirement of antibiotics continuously. Nevertheless, the closure of production sites and the impact on global trade have also affected the other side.
Key Vendor Takeaway
The leading players include Astellas Pharma, Foamix Ltd., Novartis, Roche Pharmaceuticals, GlaxoSmithKline Plc., Epiphany Biosciences, Merck & Co., Beijing Minhai Biotechnology Co., GeneOne Life Science, Inc., NAL Pharmaceuticals Ltd., and TSR, Inc. among others
The principal players are actively adopting several strategies such as geographical expansion, acquisition, product development of new and efficient technologies, etc., to maintain their position in the market. In May 2019, GSK announced that the National Medical Products Administration (NMPA) has approved Shingrix for the inhibition of herpes zoster in people aged 50 years. Shingrix is a recombinant subunit adjuvanted vaccine given intramuscularly in two doses.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2021 to 2027
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SHINGLES TREATMENT MARKET KEY PLAYERS
- Astellas Pharma
- Foamix Ltd.
- Novartis
- Roche Pharmaceuticals
- GlaxoSmithKline Plc.
- Epiphany Biosciences
- Merck & Co.
- Beijing Minhai Biotechnology Co.
- GeneOne Life Science, Inc.
- NAL Pharmaceuticals Ltd.
- TSRL, Inc.
GLOBAL SHINGLES TREATMENT MARKET, BY TREATMENT TYPE
- Antiviral medications
- Narcotic medications
- Anti-inflammatory medications
- Antihistamines
- Anticonvulsants
- Creams
- Others
GLOBAL SHINGLES TREATMENT MARKET, BY ROUTE OF ADMINISTRATION TYPE
- Tablets
- Injection
GLOBAL SHINGLES TREATMENT MARKET, BY END-USE
- Clinics
- Hospitals
- Diagnostic centres
- Home Care Settings
GLOBAL SHINGLES TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. SHINGLES TREATMENT MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Treatment Type
2.1.2. Market Snippet by Route of Administration
2.1.3. Market Snippet by End-use
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. SHINGLES TREATMENT KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. SHINGLES TREATMENT INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. SHINGLES TREATMENT MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. SHINGLES TREATMENT MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. SHINGLES TREATMENT MARKET – BY TREATMENT TYPE
7.1. Overview
7.1.1. Segment Share Analysis, By Treatment Type, 2020 & 2027 (%)
7.2. Antiviral medications
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3. Narcotic medications
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.4. Anti-inflammatory medications
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.5. Antihistamines
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.6. Anticonvulsants
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.7. Creams
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.8. Others
7.8.1. Overview
7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8. SHINGLES TREATMENT MARKET – BY ROUTE OF ADMINISTRATION
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment Type, 2020 & 2027 (%)
8.2. Tablets
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.3. Injections
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9. SHINGLES TREATMENT MARKET – BY END-USE
9.1. Overview
9.1.1. Segment Share Analysis, By End-use, 2020 & 2027 (%)
9.2. Clinics
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3. Diagnostics
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4. Hospitals
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5. Home Care Settings
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10. SHINGLES TREATMENT MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.2.4. North America Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.2.5. North America Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in North America
10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.3.11. Rest of Europe
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.11.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.3.11.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.3.11.5. Rest of the Europe Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.4.11. Rest of APAC
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.11.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.4.11.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.4.11.5. Rest of APAC Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
1.1.1. Rest of LATAM
10.5.9.6. Overview
10.5.9.7. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.9.8. Rest of LATAM Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.5.9.9. Rest of LATAM Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.5.9.10. Rest of LATAM Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2016 - 2027 (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Astellas Pharma
11.2.1.1. Company Snapshot
11.2.1.2. Financial Performance
11.2.1.3. Treatment Type Benchmarking
11.2.1.4. Strategic Initiatives
11.2.2. Foamix Ltd.
11.2.3. Novartis
11.2.4. Roche
11.2.5. GlaxoSmithKline Plc.
11.2.6. Merck & Co.
11.2.7. Epiphany Biosciences
11.2.8. Beijing Minhai Biotechnology Co.
11.2.9. GeneOne Life Science, Inc.
11.2.10. NAL Pharmaceuticals Ltd.
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
